Results 151 to 160 of about 15,631 (257)
Edward M Kerwin,1 Thomas J Ferro,2 Rinat Ariely,3 Debra E Irwin,4 Ruchir Parikh3 1Clinical Trials Division, Clinical Research Institute of Southern Oregon, PC, Medford, OR, 2Global Medical Affairs, 3Global Health Economics and Outcome Research, Teva ...
Kerwin EM+4 more
doaj
Levalbuterol reduced admissions more than racemic albuterol in children with acute asthma [PDF]
Thomas M. Ball
openalex +1 more source
(R)-Albuterol Elicits Antiinflammatory Effects in Human Airway Epithelial Cells via iNOS [PDF]
Brian N. Chorley+4 more
openalex +1 more source
Beneficial Effects of Albuterol Therapy Driven by Heliox versus by Oxygen in Severe Asthma Exacerbation [PDF]
David Lin Lee+4 more
openalex +1 more source
Background: Long-acting bronchodilators are preferred over short-acting bronchodilators in patients with stable COPD, but prospective studies are needed to determine the safety and efficacy of nebulized long-acting bronchodilators in hospitalized ...
Rajiv Dhand, MD+15 more
doaj
(S)-Albuterol increases CysLT1R expression and VEGF mRNA by normal human lung fibroblasts (NHLF) [PDF]
Marianne Frieri, A. Capetandes
openalex +1 more source
HOSPITAL ECONOMIC IMPACT IN THE TREATMENT OF ACUTE ASTHMA: A COMPARISON OF RACEMIC ALBUTEROL VERSUS LEVALBUTEROL [PDF]
David M. Schreck, Stephen Babin
openalex +1 more source
Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing [PDF]
John F. Freiler+4 more
openalex +1 more source